Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.89)
# 3,219
Out of 4,996 analysts
55
Total ratings
57.14%
Success rate
-3.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $184.60 | -0.33% | 5 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Overweight | $330 → $350 | $318.00 | +10.06% | 5 | Aug 8, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $147 → $142 | $133.55 | +6.33% | 8 | Jul 18, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $10.20 | +96.08% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $12.00 | +583.33% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $119.99 | +106.68% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $441.12 | -23.15% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.78 | +93.55% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.74 | +1,451.72% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $98.24 | +12.99% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $67.10 | +114.23% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $79.92 | -29.93% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $80.20 | -7.73% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $76.25 | +0.55% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $12.89 | +598.22% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $55.70 | - | 1 | Dec 12, 2019 |
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $184.60
Upside: -0.33%
Insulet
Aug 8, 2025
Maintains: Overweight
Price Target: $330 → $350
Current: $318.00
Upside: +10.06%
Abbott Laboratories
Jul 18, 2025
Maintains: Overweight
Price Target: $147 → $142
Current: $133.55
Upside: +6.33%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $10.20
Upside: +96.08%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $12.00
Upside: +583.33%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $119.99
Upside: +106.68%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $441.12
Upside: -23.15%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.78
Upside: +93.55%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.74
Upside: +1,451.72%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $98.24
Upside: +12.99%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $67.10
Upside: +114.23%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $79.92
Upside: -29.93%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $80.20
Upside: -7.73%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $76.25
Upside: +0.55%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $12.89
Upside: +598.22%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $55.70
Upside: -